scholarly article | Q13442814 |
P356 | DOI | 10.1006/BBRC.1998.9893 |
P8608 | Fatcat ID | release_a4bpxttpane7jasol3f3elepcy |
P3181 | OpenCitations bibliographic resource ID | 207733 |
P698 | PubMed publication ID | 9920759 |
P5875 | ResearchGate publication ID | 13367950 |
P2093 | author name string | C Di | |
D Ma | |||
G Chen | |||
H Liu | |||
J Tang | |||
Q Song | |||
Y Wang | |||
Y Zhang | |||
P2860 | cites work | Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death | Q24312211 |
harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L) | Q24532147 | ||
Bim: a novel member of the Bcl-2 family that promotes apoptosis | Q24532974 | ||
Using neural networks for prediction of the subcellular location of proteins | Q24547827 | ||
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery | Q27860586 | ||
Apoptosis in the pathogenesis and treatment of disease | Q28235731 | ||
Mechanisms and Functions of Cell Death | Q28261655 | ||
Apoptosis: molecular regulation of cell death | Q28611445 | ||
Cloning the differences between two complex genomes | Q34360785 | ||
Identifying differences in mRNA expression by representational difference analysis of cDNA | Q35004368 | ||
The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal. | Q36565586 | ||
Interleukin 3-dependent survival by the Akt protein kinase | Q36593239 | ||
Identification of genes induced by factor deprivation in hematopoietic cells undergoing apoptosis using gene-trap mutagenesis and site-specific recombination | Q37091100 | ||
Apoptosis of hemopoietic cells by the human granulocyte-macrophage colony-stimulating factor mutant E21R. | Q37676156 | ||
Genetic control of programmed cell death in Drosophila | Q38468332 | ||
Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis | Q40016977 | ||
Wild-type p53 induces diverse effects in 32D cells expressing different oncogenes. | Q40018135 | ||
Mechanisms and genes of cellular suicide | Q40605270 | ||
Life, death, and the pursuit of apoptosis. | Q40942974 | ||
Growth factor modulation of p53-mediated growth arrest versus apoptosis | Q41365779 | ||
Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis | Q41748320 | ||
Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin | Q42815989 | ||
Cell killing by the Drosophila gene reaper | Q47070113 | ||
The head involution defective gene of Drosophila melanogaster functions in programmed cell death | Q47070937 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | leukemia | Q29496 |
apoptotic process | Q14599311 | ||
positive regulation of apoptotic process | Q14818063 | ||
Programmed cell death 5 | Q21119690 | ||
P304 | page(s) | 203-10 | |
P577 | publication date | 1999-01-08 | |
P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
P1476 | title | TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal | |
P478 | volume | 254 |
Q48714703 | Acute and long-term proteome changes induced by oxidative stress in the developing brain |
Q35017205 | Adenovirus-delivered PDCD5 counteracts adriamycin resistance of osteosarcoma cells through enhancing apoptosis and inhibiting Pgp. |
Q35033194 | Anti-inflammatory effects of recombinant human PDCD5 (rhPDCD5) in a rat collagen-induced model of arthritis |
Q39991834 | AtPDCD5 Plays a Role in Programmed Cell Death after UV-B Exposure in Arabidopsis. |
Q35057796 | Attenuated monocyte apoptosis, a new mechanism for osteoporosis suggested by a transcriptome-wide expression study of monocytes |
Q50762805 | Bifurcation analysis and potential landscapes of the p53-Mdm2 module regulated by the co-activator programmed cell death 5. |
Q40271328 | Cellular uptake of exogenous human PDCD5 protein |
Q33477821 | Cerebral cavernous malformations: somatic mutations in vascular endothelial cells |
Q81152153 | Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4 (CCR4) |
Q51827727 | Comparative genomics of phylogenetically diverse unicellular eukaryotes provide new insights into the genetic basis for the evolution of the programmed cell death machinery. |
Q50431682 | Correlation of PDCD5 and apoptosis in hair cells and spiral ganglion neurons of different age of C57BL/6J mice |
Q41082402 | Deletion of Pdcd5 in mice led to the deficiency of placenta development and embryonic lethality |
Q36654687 | Determination of PDCD5 in Peripheral Blood Serum of Cancer Patients |
Q36781506 | Down-regulation of programmed cell death 5 by insulin-like growth factor 1 in osteoarthritis chondrocytes |
Q91695357 | Effects of Tumor Necrosis Factor Alpha on the Expression of Programmed Cell Death Factor 5 in Arthritis |
Q40718405 | Erythropoietin induces changes in gene expression in PC-12 cells |
Q54234810 | Expression and clinical significance of the programmed cell death 5 gene and protein in laryngeal squamous cell carcinoma. |
Q34131047 | Involvement of autophagy in cardiac remodeling in transgenic mice with cardiac specific over-expression of human programmed cell death 5 |
Q64901187 | Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma. |
Q47863989 | Literature and patent analysis of the cloning and identification of human functional genes in China |
Q36801454 | Low programmed cell death 5 expression is a prognostic factor in ovarian cancer |
Q24291344 | Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity |
Q39042840 | NF-κB p65 recruited SHP regulates PDCD5-mediated apoptosis in cancer cells |
Q34104842 | Nuclear translocation of PDCD5 (TFAR19): an early signal for apoptosis? |
Q28218291 | Overexpression of chemokine-like factor 2 promotes the proliferation and survival of C2C12 skeletal muscle cells |
Q36193355 | Overexpression of programmed cell death 5 in a mouse model of ovalbumin-induced allergic asthma |
Q64261018 | PDCD5 inhibits osteosarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with good prognosis |
Q37133925 | PDCD5 interacts with Tip60 and functions as a cooperator in acetyltransferase activity and DNA damage-induced apoptosis |
Q39292772 | PDCD5 interacts with p53 and functions as a positive regulator in the p53 pathway |
Q24323119 | PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses |
Q39333020 | PDCD5 promotes cisplatin-induced apoptosis of glioma cells via activating mitochondrial apoptotic pathway |
Q50113933 | PDCD5 regulates cell proliferation, cell cycle progression and apoptosis |
Q38936648 | PDCD5 transfection increases cisplatin sensitivity and decreases invasion in hepatic cancer cells |
Q35815852 | PDCD5-regulated cell fate decision after ultraviolet-irradiation-induced DNA damage. |
Q37611821 | Pretreatment of mice with oligonucleotide prop5 protects them from influenza virus infections |
Q43202824 | Programmed cell death 5 factor enhances triptolide-induced fibroblast-like synoviocyte apoptosis of rheumatoid arthritis. |
Q35813589 | Programmed cell death 5 mediates HDAC3 decay to promote genotoxic stress response |
Q52723717 | Programmed cell death 5 suppresses AKT-mediated cytoprotection of endothelium. |
Q24316840 | Programmed cell death protein 5 interacts with the cytosolic chaperonin containing tailless complex polypeptide 1 (CCT) to regulate β-tubulin folding |
Q36431688 | Proteome signatures of inflammatory activated primary human peripheral blood mononuclear cells |
Q35761226 | Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis |
Q39064114 | Recombinant human PDCD5 protein enhances chemosensitivity of breast cancer in vitro and in vivo |
Q47747256 | RhPDCD5 combined with dexamethasone increases antitumor activity in multiple myeloma partially via inhibiting the Wnt signalling pathway |
Q30859115 | Ser/Thr/Tyr protein phosphorylation in the archaeon Halobacterium salinarum--a representative of the third domain of life |
Q44724255 | Serum programmed cell death protein 5 (PDCD5) levels is upregulated in liver diseases. |
Q24299757 | Short interfering RNA against the PDCD5 attenuates cell apoptosis and caspase-3 activity induced by Bax overexpression |
Q32164690 | Soluble expression in Escherichia coli, purification and characterization of a human TF-1 cell apoptosis-related protein TFAR19. |
Q35609398 | Staphylococcus aureus induces hypoxia and cellular damage in porcine dermal explants |
Q24681264 | Statistical significance for genomewide studies |
Q24336263 | Studies on interactions of programmed cell death 5 (PDCD5) and its related peptides with heparin by capillary zone electrophoresis |
Q91688013 | The Molecular Evolution and Functional Divergence of Lamprey Programmed Cell Death Genes |
Q24535581 | The N-terminal 26-residue fragment of human programmed cell death 5 protein can form a stable alpha-helix having unique electrostatic potential character |
Q50235052 | The involvement of programmed cell death 5 (PDCD5) in the regulation of apoptosis in cerebral ischemia/reperfusion injury. |
Q38865247 | The p53 binding protein PDCD5 is not rate-limiting in DNA damage induced cell death |
Q37075429 | The reduced PDCD5 protein is correlated with the degree of tumor differentiation in endometrioid endometrial carcinoma |
Q52994134 | The roles of serum PDCD5 in circulating CD133 positive cells of the patients with gastric cancer. |
Q39391759 | Transfection of PDCD5 effect on the biological behavior of tumor cells and sensitized gastric cancer cells to cisplatin-induced apoptosis |
Q33703271 | Transfection of PDCD5 sensitizes colorectal cancer cells to cisplatin-induced apoptosis in vitro and in vivo |
Q44084801 | Transfer of anti-TFAR19 monoclonal antibody into HeLa cells by in situ electroporation can inhibit the apoptosis |
Q91591176 | [rhPDCD5 suppresses pro-inflammatory cytokine secretion and proliferation and induces apoptosis of activated lymphocytes from rats with collagen-induced arthritis] |
Q58481885 | t(14;19)(q32;q13): A recurrent translocation in B-cell precursor acute lymphoblastic leukemia |
Search more.